FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent
Deficiencies
|
Director
Office of Device Evaluation (HFZ400)Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies
ODE Review Staff
Purpose
This guidance describes the procedures to be used
to implement this interactive review provision. The guidance
applies to original PMA applications received by FDA on or after
February 19, 1998.
Guidance
The attached "Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies - for Use by
CDRH and Industry" was published on February 19, 1998. It
sets forth the procedures for the request, preparation, documentation,
and follow-up of "day-100" meetings.
Effective Date: February 19, 1998.
Susan Alpert, Ph.D., M.D. |
Updated 6/30/1998
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH